Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database

What is it about?

We show that guideline-concordant testing for chronic kidney disease among at-risk patients with diabetes and/or hypertension has remained low and has improved only modestly since 2013. Real-world evidence of testing rates can help raise awareness of the disease and drive early detection to improve care and save healthcare costs.

Featured Image